Vertex Announces European Commission Approval for Kalydeco® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
Vertex 宣佈歐盟委員會批准 Kalydeco® 用於治療 1 個月及以上的囊性纖維化嬰兒
Vertex Announces European Commission Approval for Kalydeco® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
Vertex 宣佈歐盟委員會批准 Kalydeco® 用於治療 1 個月及以上的囊性纖維化嬰兒
使用瀏覽器的分享功能,分享給你的好友吧